Induction of pulmonary CYP1A1 by nicotine

References

• AKIN, F. J., CHAMBERLAIN, W. J. and CHORTYK, O. T., 1975, Mouse skin tumorigenesis and induction of aryl hydrocarbon hydroxylase by tobacco smoke fractions. Journal of the National Cancer Institute, 54, 907–912.
   PubMedGoogle Scholar
• ANANDATHEERTHAVA RADA, H. K., WILLIAMS, J. F. and WECKER, L., 1993a, Differential effect of chronic nicotine administration on brain cytochrome P4501A1/2 and P4502E1. Biochemical and Biophysical Research Communications, 194, 312–318.
   PubMedGoogle Scholar
• ANANDATHEERTHAVA RADA, H. K., WILLIAMS, J. F. and WECKER, L., 1993b, The chronic administration of nicotine induces cytochrome P450 in rat brain. Journal of Neurochemistry, 60, 1941–1944.
   PubMedGoogle Scholar
• CHOMCZYNSKI, P. and SACCHI, A., 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry, 162, 156–159.
   PubMed Web of Science ®Google Scholar
• DENISSENKO, M. F., PAO, A., TANG, M. and PFEIFER, G. P., 1996, Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science, 274, 430–432.
   PubMed Web of Science ®Google Scholar
• DOLL, R. and HILL, A. B., 1950, Smoking and carcinoma of the lung. Preliminary report. British Medical Journal, ii, 739–748.
   Google Scholar
• DOLL, R. and PETO, R., 1978, Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. Journal of Epidemiology and Community Health, 32, 303–313.
   PubMed Web of Science ®Google Scholar
• FAGAN, J. B., PASTEWKA, J. V., CHALBERG, S. C., GOZUKARA, E., GUENGERICH, F. P. and GELBOIN, H. V., 1985, Noncoordiate regulation of mRNAs encoding cytochromes P-450BNF/MC-B and P-450ISF/BNF-G. Archives of Biochemistry and Biophysics, 244, 261–272.
   Google Scholar
• FLING, J., SCHOLL, H., PARK, Y., THOMAS, P. E. and IBA, M. M., 1998, CYP1A1 induction by mainstream (ms) and sidestream (ss) cigarette smoke (Cs) in rat tissues: Kinetics and dose-response relationships. Fundamental and Applied Toxicology (in press).
   Google Scholar
• GEBREMICHAEL, A., TULLIS, K., DENISON, M. S., CHEEK, J. M. and PINKERTON, K. E., 1996, Ah-receptor-dependent modulation of gene expression by aged and diluted sidestream cigarette smoke. Toxicology and Applied Pharmacology, 141, 76–83.
   PubMed Web of Science ®Google Scholar
• GODDEN, P. M. M., KASS, G., MAYER, R. T. and BURKE, M. D., 1987, The effects of cigarette smoke compared to 3-methylcholanthrene and phenobarbitone on alkoxyresorufin metabolism by lung and liver microsomes from rats. Biochemical Pharmacology, 36, 3393–3398.
   Google Scholar
• GRADELET, S., ASTOR, P., PINEAU, T., CANIVENC, M.-C., SIESS, M.-H., LECLERC, J. and LESCA, P., 1997, Ah receptor-dependent CYP1A induction by two carotenoids, canthaxanthin and )3-apo-8"-carotenal, with no affinity for TCDD binding site. Biochemical Pharmacology, 54, 307–315.
   Google Scholar
• GUENGERICH, F. P., 1993, Purification and characterization of lung enzymes involved in xenobiotic metabolism. In Metabolic Activation and Toxicity of Chemical Agents to Lung Tissue and Cells, edited by T. E. Gram (Oxford: Pergamon), pp. 77–87.
   Google Scholar
• HANKINSON, O., 1983, Dominant and recessive aryl hydrocarbon hydroxylase-deficient mutants of mouse hepatoma line HEPA 1 and assignment of recessive mutants to three complementation groups. Somatic Cell Genetics, 9, 497–514.
   PubMedGoogle Scholar
• HANKINSON, O., 1995, The aryl hydrocarbon receptor complex. Annual Review of Pharmacology and Toxicology, 35, 307–340.
   PubMed Web of Science ®Google Scholar
• HAPGOOD, J., CUTHILL, S., DENIS, M., POELLINGER, L. and GUSTAFSSON, J.-A., 1989, Specific Protein-DNA interactions at the xenobiotic-responsive element: copurification of dioxin receptor and DNA-binding activity. Proceedings of the National Academy of Sciences, USA, 86, 60–64.
   Google Scholar
• HECHT, S. S. AND HOFFMANN, D, 1988, Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis, 9, 875–884.
   PubMed Web of Science ®Google Scholar
• IBA, M. M. and ALAM, J., 1995, Heme oxygenase-1 mRNA levels, metallothionein mRNA levels, lipid peroxidation and microsomal CYP1A activities in rats treated with 3,3'-dichlorobenzidine and some other inducers of P450. Redox Report, 1, 279–286.
   PubMed Web of Science ®Google Scholar
• IBA, M. M., BENNETT, S., STORCH, A. and THOMAS, P. E., 1993, Synergistic induction of CYP1A1 and CYP1A2 by acetone in combination with pyridine. Cancer Letters, 74, 69–74.
   PubMedGoogle Scholar
• IBA, M. M. and THOMAS, P. E., 1988, Activation of 3,3'-dichlorobenzidine in rat liver microsomes to mutagens: involvement of cytochrome P-450d. Carcinogenesis, 9, 717–723.
   PubMed Web of Science ®Google Scholar
• INTERNATIONAL AGENCY FOR RESEARCH ON CANCER, 1986, Tobacco Smoking. IARC Monographs On the Evaluation of the Carcinogenic Risk of Chemicals to Humans, 38 (Lyon: World Health Organization).
   Google Scholar
• JACOB, P., BENOWITZ, N. L. and SHULGIN, A. T., 1988, Recent studies of nicotine metabolism in humans. Pharmacology and Biochemistry of Behavior, 30, 249–253.
   PubMed Web of Science ®Google Scholar
• KELLERMAN, G., SHAW, C. R. and LUYTEN -KELLERMAN, M., 1973, Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. New England Journal of Medicine, 289, 934–937.
   Google Scholar
• KIRK, R. E., 1982, Experimental Design: Procedures for the Behavioral Sciences (Cole, Montery: Brooks).
   Google Scholar
• KLEMAN, M. I., OVERICK, E., MASON, G. G. F. and GUSTAFSSON, J.-A., 1992, In vitro activation of the dioxin receptor to a DNA-binding form by food-borne heterocyclic amines. Carcinogenesis, 13, 1619–1624.
   Google Scholar
• KOURI, R. E., MCKINNEY, C. E., SLOMIANY, D. J., SNODGRASS, D. R., WRAY, N. P. and MCLEMORE, T. L., 1982, Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analysed in cryopreserved lymphocytes. Cancer Research, 42, 5030–5037.
   PubMed Web of Science ®Google Scholar
• KuNrzmAN, R., PANTUCK, E. J., KAPLAN, S. A. and CONNEY, A. H., 1977, Phenacetin metabolism: effect of hydrocarbons and cigarette smoking. Clinical Pharmacology and Therapeutics, 22, 757–764.
   PubMedGoogle Scholar
• KYEREMATEN, G. A., PASSANATI, G. T., GREENE, F. E. AND VESSEL, E. S., 1983, Time-dependent induction of hepatic drug metabolism in rats by nicotine. Life Sciences, 32, 551–556.
   PubMedGoogle Scholar
• KYEREMATEN, G. A., OWENS, G. F., CHATTOPADHYAY, B., DEBETHIZY, J. D. and VESSEL, E. S., 1988, Sexual dimorphism of nicotine metabolism and distribution in the rat. Studies in vivo and in vitro. Drug Metabolism and Disposition, 16, 823–282.
   PubMed Web of Science ®Google Scholar
• LINDQUIST, N. G. and Ullberg, S., 1974, Autoradiography of intravenously injected '4C-nicotine indicates long-term retention in the respiratory tract. Nature, 248, 600–602.
   PubMedGoogle Scholar
• LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1961, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 256–275.
   Google Scholar
• MCLEMORE, T. L., ADELBERG, S., Liu, M. C., MCMAHON, N. A., Yu, S. J., HUBBARD, W. C., C ZERWINSKI M WOOD, T. G., STOREG, R., LUBERT, R. A., EGGLESTON, J. C ., BOYD, M. R. and HINES, R. N., 1990, Expression of CYP1A1 gene in patients with lung cancer: Evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. Journal of the National Cancer Institute, 82, 1333–1339.
   Google Scholar
• NAKACHI, K., 'Am', K., HAYASHI, S.-I., WATANABE, J. and KAWAJIRI, K., 1991, Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Research, 51, 5177–5180.
   Google Scholar
• NEBERT, D. W., 1989, The [Ali] locus: genetic differences in toxicity, cancer, mutation and birth defects. CRC Critical Reviews in Toxicology, 20, 153–174.
   Google Scholar
• NEBERT, D. W., PETERSEN, D. D. and PUG A., 1991, Human AH locus polymorphism and cancer: Inducibility of CYP1A1 and other genes by combustion products and dioxin. Pharmacogenetks, 1, 68–78.
   PubMedGoogle Scholar
• OK', A. B., RIDDICK, D. S. and HARPER, P. A., 1994, The Ah receptor: Mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Toxicology Letters, 70, 1–22.
   PubMedGoogle Scholar
• PARKE, D. V., 1968, The Biochemistry of Foreign Compounds (Oxford: Pergamon).
   Google Scholar
• PETERSEN, D. D., MCKINNEY, C. E., IKEYA, K., SMITH, H. H., BALE, A. E., MCBRIDE, O. W. and NEBERT, D. W., 1991, Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. American Journal of Human Genetics, 48, 720–725.
   PubMed Web of Science ®Google Scholar
• POHL, R. J. and FOUTS, J. R., 1980, A rapid method for assaying the metabolism 7-ethoxyresorufin by microsomal cellular fractions. Analytical Biochemistry, 107, 150–155.
   PubMed Web of Science ®Google Scholar
• POLAND, A. and KNUTSON, J. C., 1982, 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related aromatic hydrocarbons: examination of the mechanisms of toxicity. Annual Review of Pharmacology and Toxicology, 22, 517–524.
   PubMed Web of Science ®Google Scholar
• REMMER, H., 1987, Passively inhaled tobacco smoke: a challenge to toxicology and preventive medicine. Archives of Toxicology, 61, 89–104.
   PubMed Web of Science ®Google Scholar
• RUDDON, R. W. and COHEN, A. M., 1970, Alteration of enzyme activity in rat liver following the acute and chronic administration of nicotine. Toxicology and Applied Pharmacology, 16, 613–625.
   PubMedGoogle Scholar
• RYAN, D. E. and LEVIN, W, 1990, Purification and characterization of hepatic microsomal cytochrome P-450. Pharmacology and Therapeutics, 45, 153–239.
   PubMed Web of Science ®Google Scholar
• SADAR, M. D., ASH, R., SUNDQVIST, J., OLSSON, P. E. and ANDERSSON T. B., 1996, Phenobarbital induction of CYP1A1 gene expression in a primary culture of rainbow trout hepatocytes. Journal of Biological Chemistry, 271, 17635–17643.
   Google Scholar
• SAFE, S., 1990, Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs) and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Critical Reviews in Toxicology, 21, 51–88.
   PubMed Web of Science ®Google Scholar
• SCHMOLDT, A., JAcos, J. and GRIMMER, G., 1988, Metabolism of benz(a)anthracene catalysed by liver microsomes of untreated and nicotine-pretreated rats. Klin Wochenschrift, 66, 108–113.
   PubMedGoogle Scholar
• SCHOLL, H. and IBA, M. M., 1997, Pharmacokinetics of and CYP1A induction by pyridine and acetone in the rat: interactions and effects of route of exposure. Xenobiotka, 27, 265–277.
   PubMed Web of Science ®Google Scholar
• ScHoLL, H., FUNG, J., THOMAS, P. E., ALAM J. and IBA, M. M., 1997, Interactive induction of CYP1A by pyridine and acetone: dose-response relationships. Fundamental and Applied Toxicology, 36, 87.
   Google Scholar
• SCHULLER, H. M., 1989, Cell type specific, receptor-mediated modulation of growth kinetics in human lung cancer cell lines by nicotine and tobacco-related nitrosamines. Biochemical Pharmacology, 38, 3439–3442.
   PubMed Web of Science ®Google Scholar
• SHEN, E. S. and WHITLOCK, J. P., Jr, 1992, Protein-DNA interactions at the dioxin-responsive enhancer: mutational analysis of the DNA-binding site for the liganded Ah receptor. Journal of Biological Chemistry, 267, 6815–6819.
   Google Scholar
• SHIRAKI, H. and GUENGERICH, F. P., 1984, Turnover of membrane proteins: kinetics of induction and degradation of seven forms of rat liver microsomal cytochrome P-450, NADPH-cytochrome P450 reductase and epoxide hydrolase. Archives of Biochemistry and Biophysics, 255, 86–96.
   Google Scholar
• SHou, M., KORZEKWA, K. R., CRESPI C., GONZALEZ. F. J. and GELBOIN, H. V., 1994, The role of 12 cDNA-expressed human, rodent and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7,8-dihydrodiol. Molecular Carcinogenesis, 10, 159–168.
   Google Scholar
• SIMBERG, N. and UOTILA, P., 1978, Stimulatory effect of cigarette smoke on the metabolism and covalent binding of benzo(a)pyrene in the trachea of the rat. International Journal of Cancer, 22, 28–31.
   PubMedGoogle Scholar
• THE SMOKING CESSATION CLINICAL PRACTICE GUIDELINE PANEL AND STAFF, 1996, The Agency for Health Care Policy and Research: Smoking Cessation Clinical Practice Guideline, 1996. journal of the American Medical Association, 275, 1270–1280.
   PubMed Web of Science ®Google Scholar
• THOMAS, P. E., REIK, L. M., RYAN, D. E. and LEVIN, W., 1984, Characterization of nine monoclonal antibodies against rat hepatic cytochrome P-450c. Delineation of at least five spatially distinct epitopes. Journal of Biological Chemistry, 259, 3890–3899.
   PubMed Web of Science ®Google Scholar
• US PuBLIc HEALTH SERVICE, 1988, The Health Consequences of Smoking: Nicotine and Nicotine Addiction.
   Google Scholar
• DHHS Publication No. (PHS) 88-223-627 (Washington: Government Printing Office). WELCH, R. M. and CONNEY, A. H., 1971, Cigarette smoke: stimulatory effect of on metabolism of 3,4 benzpyrene. Life Sciences, 10, 215–221.
   Google Scholar
• WELCH, R. M., HARRISON, Y. E., CONY, A. H., POPPERS, P. J. and FINSTER M., 1968, Cigarette smoking: Stimulatory effect on metabolism of 3,4-benzpyrene by enzymes in human placenta. Science, 160, 541–542.
   Google Scholar
• WRIGHT, S. C., ZHONG J., ZHENG, H. and LARRICK, J. W., 1993, Nicotine inhibition of apoptosis suggests a role in tumor promotion. F ASEB Journal, 7, 1045–1051.
   Google Scholar
• WYNDER, E. L. and HOFFMANN, D., 1967, Tobacco and Tobacco Smoke. Studies in Experimental Carcinogenesis (New York: Academic).
   Google Scholar
• WYNDER, E. L. and HOFFMANN, D., 1979, Tobacco and health. A societal challenge. New England Journal of Medicine, 300, 894–903.
   PubMed Web of Science ®Google Scholar
• YAMAMOTO, I., NAGAI, K., KIMURA, H. and IWATSUBO, K., 1966, Nicotine and some carcinogens in special reference to the hepatic drug-metabolizing enzymes. Japanese Journal of Pharmacology, 16, 183–190.
   PubMedGoogle Scholar
• YANG, H.-Y. L., NAMKUNG, M. J. and JucHAu, M. R., 1988, Cytochrome-P450-dependent biotrans-formation of a series of phenoxazone ethers in the rat conceptus during early organogenesis. Molecular Pharmacology, 349, 67–73.
   Google Scholar
• Yrm, S. H. and HEE, S. Q., 1995, Genotoxicity of nicotine and cotinine in the bacterial luminescence test. Mutation Research, 335, 275–283.
   PubMedGoogle Scholar